reminder: what martin said about fda approva, page-2

birdseye,
Great time for a re-post of that info. Very wise words for MR and so true re a seismic shift. Prima's own announcement are very important, however a 'clearing of the path' in such great style, which intoduces the first to market in this type of treatment is so important for companies like Prima.

This has caused a re-think and change in attitude by the US FDA and will hopefully place Prima in the spotlight of international investors.

I also believe investors have learnt hard lessons with companies which have run strongly and then experienced a 50+% retrace, leaving many new investors pondering whether their investment was wise. I see a steady growth with less frequent and severe pull backs.

regards

dc